Financial Statements Notes to the Financial Statements 5 employees continued Staff numbers The monthly average number of people employed by the Group, including Directors, during the year was: 2014 2013 000 000 Continuing operations ENA 12.5 12.5 RUMEA 7.2 7.6 LAPAC 15.6 15.1 Other 1.2 1.2 discontinued operations RB Pharmaceuticals 0.7 0.7 37.2 37.1 6 net Finance expense 2014 2013 m m Finance income Interest income on cash and cash equivalents 27 25 Total finance income 27 25 Finance expense Interest payable on borrowings 38 31 Net pension plan interest 8 8 Amortisation of issue costs of bank loans 8 11 Other finance expense 11 6 Total finance expense 65 56 net finance expense 38 31 All net finance expense relates to continuing operations only.
Discontinued operations were historically funded by the Group.
7 income Tax expense 2013 1 2014 restated m m Current tax 549 587 Prior year adjustments 22 52 Total current tax 527 535 Origination and reversal of temporary differences 65 13 Impact of changes in tax rates 95 Total deferred tax note 11 65 82 income tax expense 462 453 1 Restated for the impact of discontinued operations.
Refer to note 27 for tax charge relating to discontinued operations.
The standard rate of corporation tax in the UK changed from 23% to 21% with effect from 1 April 2014.
Accordingly, the Companys profits for the year ended 31 December 2014 are taxed at an effective rate of 21.5% 2013: 23.25%.
1 UK income tax for 2014 of 73m 2013 restated : 68m is included within current tax and is calculated at 21.5% 2013: 23.25% of the estimated assessable profit for the year.
Taxation for other jurisdictions is calculated at the rates prevailing in the relevant jurisdictions.
RB Annual Report and Financial Statements 2014 86
